Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
M. Elaine Husni, MD, MPH, is Vice Chair of Rheumatology and Director, Arthritis and Musculoskeletal Center. She is a Staff Physician in the Orthopedic and Rheumatologic Institute at Cleveland Clinic. Dr. Husni is also an Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Husni joined the Clinic in 2005 following a faculty appointment at Harvard Medical School, Brigham and Women's Hospital. She completed her internship and residency at the Beth Israel Deaconess Hospital at Harvard Medical School, and she trained in Rheumatology at the Brigham and Women's Hospital at Harvard Medical School. Dr. Husni received her MD and MPH degrees at Boston University School of Medicine.
Dr. Husni's research interests include examining health outcomes of patients with rheumatoid arthritis and psoriatic arthritis, specifically in the area of cardiovascular disease. She is the current recipient of the Clinical Investigator Award by the American College of Rheumatology for this work. She is involved in a number of rheumatology clinical trials at Cleveland Clinic and serves on the Executive Committee of the PRECISION trial.
She also has a research focus on orthopaedic outcomes with a specific research interest in the use of clinical pathways in patients undergoing total joint arthroplasty. She is a past recipient of the Physician Scientist Development Award by the American College of Rheumatology for this research. She is currently Director of Musculoskeletal Outcomes research and the fellow's research committee for the Rheumatology Department. She is currently on the medical and scientific committee for the Arthritis Foundation of the Northeastern Ohio Chapter. Dr. Husni has had the opportunity to mentor both rheumatology and orthopedic research trainees and this has been one of her most rewarding experiences.
Osteoarthritis, Psoriatic Arthritis, Rheumatoid Arthritis, Joint pain, use of complementary and alternative medicine for arthritis and health outcomes research
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/30/2014, Dr. Husni has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.